Evidence map›Paper›PMID 41465611›Full record

ArticleInternational journal of molecular sciences2025

Low Levels of Mouse γδ T Cell Development Persist in the Presence of Null Mutants of the LAT Adaptor.

Mikel M Arbulo-Echevarria, Luis M Fernandez-Aguilar, Elke Kurz, Inmaculada Vico-Barranco, Raquel Muñoz-Fernández, Isaac Narbona-Sánchez, Manuel Carrasco, Bernard Malissen, Michael L Dustin, Enrique Aguado

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mikel M Arbulo-EchevarriaDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0000-0002-1453-6880
Luis M Fernandez-AguilarDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0000-0002-3050-3907
Elke KurzKennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX1 7FY, UK.ORCID 0000-0002-9446-4943
Inmaculada Vico-BarrancoDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0000-0002-4279-7244
Raquel Muñoz-FernándezDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0009-0004-1179-1714
Isaac Narbona-SánchezDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0000-0003-1696-267X
Manuel CarrascoDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.
Bernard MalissenCentre d'Immunologie de Marseille-Luminy (CIML), Aix Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), 13009 Marseille, France.ORCID 0000-0003-1340-9342
Michael L DustinKennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX1 7FY, UK.ORCID 0000-0003-4983-6389
Enrique AguadoDepartment of Biomedicine, Biotechnology and Public Health, Universidad de Cádiz, 11002 Cádiz, Spain.ORCID 0000-0002-7232-2661

Funding

Agencia Estatal de Investigación PID2020-113943RB-I00Biomedical Research and Innovation Institute of Cadiz LI19/I14NCO15Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS) 2024-I2M-2-001-1Consejería de Universidad, Investigación e Innovación PY20_01297European Research Council 787300Kennedy Trust for Rheumatology Research MSP 12 13 21Salvador de Madariaga Mobility Program from the Spanish Ministry of Science PRX17/00327Universidad de Cádiz PR2022-037Wellcome Trust PRF 100262Z/12/ZZhongyuan Academician Fund from Henan Province C24185
6 · The paper itself

Abstract

Activation through the T cell receptor (TCR) initiates a signaling cascade in T cells that induces extensive molecular and cellular changes. The adaptor protein Linker for Activation of T cells (LAT) plays an essential role in transducing activation and regulatory signals downstream of the TCR. Phosphorylation of LAT tyrosine residues recruits multiple signaling proteins, leading to the assembly of the LAT signalosome, which is crucial for relaying signals that regulate T cell development and function. We previously showed that substitution of a negatively charged amino acid segment preceding the fifth tyrosine residue of LAT (Tyr127 in humans or Tyr132 in mouse LAT) enhances some early TCR signaling events, whereas downstream responses, such as Ca

Indexed as

Adaptor Proteins, Signal TransducingMembrane ProteinsMutationReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesAnimalsCell DifferentiationMiceMice, Inbred C57BLMice, KnockoutSignal TransductionAdaptor Proteins, Signal TransducingLat protein, mouseMembrane ProteinsReceptors, Antigen, T-Cell, gamma-deltaLATsignalingTCRγδ T cell

Identifiers

PMID41465611
PMCPMC12734389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.